Cargando…

L-arginine conjugates of bile acids-a possible treatment for non-alcoholic fatty liver disease

BACKGROUND: Non-alcoholic fatty liver disease (NAFLD) is a continuum of diseases that include simple steatosis and non-alcoholic steatohepatitis (NASH) ultimately leading to cirrhosis, hepatocellular carcinoma and end stage liver failure. Currently there is no approved treatment for NASH. It is know...

Descripción completa

Detalles Bibliográficos
Autores principales:	Voloshin, Irina, Hahn-Obercyger, Michal, Anavi, Sarit, Tirosh, Oren
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BioMed Central 2014
Materias:	Research
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4021351/ https://www.ncbi.nlm.nih.gov/pubmed/24750587 http://dx.doi.org/10.1186/1476-511X-13-69

Ejemplares similares

Non-alcoholic fatty liver disease, to struggle with the strangle: Oxygen availability in fatty livers
por: Anavi, Sarit, et al.
Publicado: (2017)

Fatty acids-stress attenuates gluconeogenesis induction and glucose production in primary hepatocytes
por: Budick-Harmelin, Noga, et al.
Publicado: (2012)

Steatosis-induced proteins adducts with lipid peroxidation products and nuclear electrophilic stress in hepatocytes
por: Anavi, Sarit, et al.
Publicado: (2014)

Serum Malondialdehyde is Associated with Non-Alcoholic Fatty Liver and Related Liver Damage Differentially in Men and Women
por: Zelber-Sagi, Shira, et al.
Publicado: (2020)

Hypoxic Signaling and Cholesterol Lipotoxicity in Fatty Liver Disease Progression
por: Tirosh, Oren
Publicado: (2018)

Bile Acids and Dysbiosis in Non-Alcoholic Fatty Liver Disease
por: Mouzaki, Marialena, et al.
Publicado: (2016)

Bile acids and sphingolipids in non-alcoholic fatty liver disease
por: Jackson, Kaitlyn G., et al.
Publicado: (2022)

Cholesterol Induces Nrf-2- and HIF-1α-Dependent Hepatocyte Proliferation and Liver Regeneration to Ameliorate Bile Acid Toxicity in Mouse Models of NASH and Fibrosis
por: Kaminsky-Kolesnikov, Yula, et al.
Publicado: (2020)

Targeting the ileal bile salt transporter in the treatment of non-alcoholic fatty liver disease
por: Jansen, Peter L. M.
Publicado: (2021)

Non-alcoholic fatty liver and the gut microbiota
por: Bashiardes, Stavros, et al.
Publicado: (2016)

Sustaining Intravitreal Residence With L-Arginine Peptide-Conjugated Nanocarriers
por: Li, Hao, et al.
Publicado: (2017)

Why Bile Acids Are So Important in Non-Alcoholic Fatty Liver Disease (NAFLD) Progression
por: Gottlieb, Aline, et al.
Publicado: (2019)

The Role of Gut Microbiota-Bile Acids Axis in the Progression of Non-alcoholic Fatty Liver Disease
por: Ni, Yiming, et al.
Publicado: (2022)

Silymarin’s Protective Effects and Possible Mechanisms on Alcoholic Fatty Liver for Rats
por: Zhang, Wei, et al.
Publicado: (2013)

Fatty liver diseases, bile acids, and FXR
por: Zhu, Yan, et al.
Publicado: (2016)

Biological tuners to reshape the bile acid pool for therapeutic purposes in non-alcoholic fatty liver disease
por: Gillard, Justine, et al.
Publicado: (2023)

The Crosstalk between Gut Microbiota and Bile Acids Promotes the Development of Non-Alcoholic Fatty Liver Disease
por: Li, Zhonglin, et al.
Publicado: (2023)

The Possible Role of Helicobacter pylori Infection in Non-alcoholic Fatty Liver Disease
por: Cheng, Dan-dan, et al.
Publicado: (2017)

Arginine Methylation of Integrin Alpha-4 Prevents Fibrosis Development in Alcohol-Associated Liver Disease
por: Schonfeld, Michael, et al.
Publicado: (2022)

Non-Alcoholic Fatty Liver Disease: The Bile Acid-Activated Farnesoid X Receptor as an Emerging Treatment Target
por: Fuchs, Michael
Publicado: (2012)

The Associations between Circulating Bile Acids and the Muscle Volume in Patients with Non-alcoholic Fatty Liver Disease (NAFLD)
por: Kobayashi, Yoshinao, et al.
Publicado: (2017)

Hyperoside attenuates non-alcoholic fatty liver disease in rats via cholesterol metabolism and bile acid metabolism
por: Wang, Songsong, et al.
Publicado: (2021)

Effects of high oleic acid peanuts on mice’s liver and adipose tissue metabolic parameters and gut microbiota composition
por: Anavi-Cohen, Sarit, et al.
Publicado: (2023)

Non-alcoholic fatty liver disease is associated with dysregulated bile acid synthesis and diarrhea: A prospective observational study
por: Appleby, Richard N., et al.
Publicado: (2019)

Gut Microbiota and Plasma Bile Acids Associated with Non-Alcoholic Fatty Liver Disease Resolution in Bariatric Surgery Patients
por: Pérez-Rubio, Álvaro, et al.
Publicado: (2023)

Conjugated secondary 12α-hydroxylated bile acids promote liver fibrogenesis
por: Xie, Guoxiang, et al.
Publicado: (2021)

THE RELATION BETWEEN THE FAT CONTENT OF THE BILE AND FATTY CHANGES IN THE LIVER
por: Le Count, Edwin R., et al.
Publicado: (1914)

Bile Acid Receptors and the Gut–Liver Axis in Nonalcoholic Fatty Liver Disease
por: Xue, Rui, et al.
Publicado: (2021)

Characterization of long-chain fatty acid-linked bile acids: a major conjugation form of 3β-hydroxy bile acids in feces
por: Takei, Hajime, et al.
Publicado: (2022)

The Importance of the Fatty Acid Transporter L-Carnitine in Non-Alcoholic Fatty Liver Disease (NAFLD)
por: Savic, Dragana, et al.
Publicado: (2020)

Editorial: Pharmacology of L-Arginine and L-Arginine-Rich Food
por: Poeggeler, Burkhard, et al.
Publicado: (2021)

Toll-like receptor 1 as a possible target in non-alcoholic fatty liver disease
por: Baumann, Anja, et al.
Publicado: (2021)

Predictors for advanced fibrosis in morbidly obese non-alcoholic fatty liver patients
por: Zelber-Sagi, Shira, et al.
Publicado: (2017)

The association of serum total bile acid with non-alcoholic fatty liver disease in Chinese adults: a cross sectional study
por: Zhang, Ziyu, et al.
Publicado: (2020)

Portal lymphadenopathy predicts non-alcoholic steatohepatitis and advanced fibrosis in non-alcoholic fatty liver disease
por: Daher, Saleh, et al.
Publicado: (2018)

Role of Bile Acids in Dysbiosis and Treatment of Nonalcoholic Fatty Liver Disease
por: Wang, Caihua, et al.
Publicado: (2019)

Saroglitazar in patients with non-alcoholic fatty liver disease and diabetic dyslipidemia: a prospective, observational, real world study
por: Goyal, Omesh, et al.
Publicado: (2020)

Increased levels of conjugated bile acids are associated with human bile reflux gastritis
por: Zhao, Aihua, et al.
Publicado: (2020)

Autophagy in non-alcoholic fatty liver disease and alcoholic liver disease()
por: Khambu, Bilon, et al.
Publicado: (2018)

Relationship between non-alcoholic fatty liver disease and inflammation in patients with non-alcoholic fatty liver
por: Foroughi, Mehdi, et al.
Publicado: (2016)

Cannot write session to /tmp/vufind_sessions/sess_eckk74cakdahqgbqjvbneda0pu